Table 1.
Clinical characteristics of the study population.
| Men | Women | |
| Number (n) | 23 | 7 |
| Age (mean ± SD, years) | 40 ± 11 | 36 ± 16 |
| BSA (m2) | 2 ± 0.1 | 1.7 ± 0.1 |
| LV-EF* | 55 ± 7 | 60 ± 4 |
| Sinus rhythm | 23 | 7 |
| HR | 66 ± 9 | 70 ± 13 |
| Significant valvular disease | 1 | 1 |
| DCM | 1 | 0 |
| Diabetes | 2 | 0 |
| Previous AMI | 1 | 0 |
| Hypertonic | 1 | 1 |
| CABG | 1 | 0 |
| PM | 1 | 0 |
| ICD | 1 | 0 |
| Heart failure | 2 | 0 |
| HCM | 1 | 0 |
* By 3DE, HR: heart rate, DCM: dilated cardiomyopaty, AMI: acute myocardial infarction, CABG: coronary artery bypass grafting, PM: Pacemaker, ICD: implantable cardiovertor defibrillator, HCM: hypertrophic cardiomyopaty.